Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06619756 · ClinicalTrials.gov registry record · NA
Anomia Treatment Predictors
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06619756: Completed NA study, sponsored by State University of New York at Buffalo.
NCT06619756 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06619756, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment. Researchers will compare Phonomotor Treatment and Phonological Components Analysis to see which treatment is more beneficial, and for whom. Participants will engage in both treatments over several months.
Primary Outcome
Picture naming of trained words
Interventions
- BEHAVIORAL Phonomotor Treatment (PMT)
- BEHAVIORAL Phonological Components Analysis (PCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2024-09-18 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
What the finished NCT06619756 record still lists
NCT06619756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Phonomotor Treatment (PMT) is the first listed.
NCT06619756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06619756 about?
NCT06619756 is a clinical study titled "Anomia Treatment Predictors". The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment. Researchers will compare Phonomotor Treatment and Phonological Components Anal...
What is the current status of trial NCT06619756?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2024-09-18. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT06619756?
The interventions under investigation include: Phonomotor Treatment (PMT) (BEHAVIORAL), Phonological Components Analysis (PCA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06619756?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06619756's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI